What is Opus Genetics's other accrued liabilities?

Opus Genetics (IRD) reported other accrued liabilities of $15K in Q1 2026.

How has Opus Genetics's other accrued liabilities changed year-over-year?

Opus Genetics's other accrued liabilities decreased by 96.1% year-over-year, from $380K to $15K.

What is the long-term trend for Opus Genetics's other accrued liabilities?

Over 5 years (2020 to 2025), Opus Genetics's other accrued liabilities has grown at a -9.7% compound annual growth rate (CAGR), from $25K to $15K.

Opus Genetics IRD Other accrued liabilities

Other accrued liabilities at other companies

Prime MedicinePRME

——

PrecigenPGEN

——

BridgeBio PharmaBBIO

——

HRO

HarrowHROW

——

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's other accrued liabilities?: Opus Genetics (IRD) reported other accrued liabilities of $15K in Q1 2026.
How has Opus Genetics's other accrued liabilities changed year-over-year?: Opus Genetics's other accrued liabilities decreased by 96.1% year-over-year, from $380K to $15K.
What is the long-term trend for Opus Genetics's other accrued liabilities?: Over 5 years (2020 to 2025), Opus Genetics's other accrued liabilities has grown at a -9.7% compound annual growth rate (CAGR), from $25K to $15K.